Cargando…
HIV low-level persistent viremia under new antiretroviral regimens: what we have learned up to this point?
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4240086/ http://dx.doi.org/10.1186/1471-2334-14-S7-O2 |
| _version_ | 1782345683990216704 |
|---|---|
| author | Gheorghiță, Valeriu Benea, Loredana Barbu, Alina Elena Anghel, Flavius Moroti, Ruxandra Florea, Dragoş Benea, Otilia Elisabeta Căruntu, Florin Alexandru |
| author_facet | Gheorghiță, Valeriu Benea, Loredana Barbu, Alina Elena Anghel, Flavius Moroti, Ruxandra Florea, Dragoş Benea, Otilia Elisabeta Căruntu, Florin Alexandru |
| author_sort | Gheorghiță, Valeriu |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4240086 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2014 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-42400862014-11-25 HIV low-level persistent viremia under new antiretroviral regimens: what we have learned up to this point? Gheorghiță, Valeriu Benea, Loredana Barbu, Alina Elena Anghel, Flavius Moroti, Ruxandra Florea, Dragoş Benea, Otilia Elisabeta Căruntu, Florin Alexandru BMC Infect Dis Oral Presentation BioMed Central 2014-10-15 /pmc/articles/PMC4240086/ http://dx.doi.org/10.1186/1471-2334-14-S7-O2 Text en Copyright © 2014 Gheorghiță et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Oral Presentation Gheorghiță, Valeriu Benea, Loredana Barbu, Alina Elena Anghel, Flavius Moroti, Ruxandra Florea, Dragoş Benea, Otilia Elisabeta Căruntu, Florin Alexandru HIV low-level persistent viremia under new antiretroviral regimens: what we have learned up to this point? |
| title | HIV low-level persistent viremia under new antiretroviral regimens: what we have learned up to this point? |
| title_full | HIV low-level persistent viremia under new antiretroviral regimens: what we have learned up to this point? |
| title_fullStr | HIV low-level persistent viremia under new antiretroviral regimens: what we have learned up to this point? |
| title_full_unstemmed | HIV low-level persistent viremia under new antiretroviral regimens: what we have learned up to this point? |
| title_short | HIV low-level persistent viremia under new antiretroviral regimens: what we have learned up to this point? |
| title_sort | hiv low-level persistent viremia under new antiretroviral regimens: what we have learned up to this point? |
| topic | Oral Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4240086/ http://dx.doi.org/10.1186/1471-2334-14-S7-O2 |
| work_keys_str_mv | AT gheorghitavaleriu hivlowlevelpersistentviremiaundernewantiretroviralregimenswhatwehavelearneduptothispoint AT benealoredana hivlowlevelpersistentviremiaundernewantiretroviralregimenswhatwehavelearneduptothispoint AT barbualinaelena hivlowlevelpersistentviremiaundernewantiretroviralregimenswhatwehavelearneduptothispoint AT anghelflavius hivlowlevelpersistentviremiaundernewantiretroviralregimenswhatwehavelearneduptothispoint AT morotiruxandra hivlowlevelpersistentviremiaundernewantiretroviralregimenswhatwehavelearneduptothispoint AT floreadragos hivlowlevelpersistentviremiaundernewantiretroviralregimenswhatwehavelearneduptothispoint AT beneaotiliaelisabeta hivlowlevelpersistentviremiaundernewantiretroviralregimenswhatwehavelearneduptothispoint AT caruntuflorinalexandru hivlowlevelpersistentviremiaundernewantiretroviralregimenswhatwehavelearneduptothispoint |